Viewing Study NCT00496756

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:28 PM
Ignite Modification Date: 2026-02-22 @ 12:47 AM
Study NCT ID: NCT00496756
Status: TERMINATED
Last Update Posted: 2023-10-26
First Post: 2007-07-03
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer
Sponsor: University of Nebraska
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kidney Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None clear cell renal cell carcinoma View
None stage III renal cell cancer View
None stage IV renal cell cancer View
None recurrent renal cell cancer View